Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa.
Daniel Tobias MichaeliSophia StoychevaSimon Mashudu MarcusWenjia ZhangJulia Caroline MichaeliThomas MichaeliPublished in: Clinical drug investigation (2022)
The introduction of nonavalent for bivalent HPV vaccination is a cost-effective intervention in South Africa. HPV vaccination should be part of a multifaceted public health strategy entailing screening, condoms, and education of all stakeholders to reduce the significant burden of sexual transmitted diseases in South Africa. Sex-neutral and catch-up vaccinations are subjects for further research.